← Back to Search

CHW Support for Advanced Cancer Care (DeCIDE-PC Trial)

N/A

Waitlist Available

Led By Fabian M Johnston, MD, MHS

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Intact cognition and ability to provide informed consent

Self-identified African American patients with advanced (AJCC stage III or IV) solid organ malignancy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months after enrollment

Awards & highlights

DeCIDE-PC Trial Summary

This trial will compare the quality of life of African American patients with advanced cancer who receive standard care to those whose care is supplemented with community health worker support.

Who is the study for?

This trial is for self-identified African American adults over 18 with advanced solid organ cancer (stage III or IV), who speak English and can consent. It's not specified who cannot join, but typically those with cognitive issues or other exclusions may be ineligible.Check my eligibility

What is being tested?

The study tests if adding community health worker support to standard care improves the quality of life for patients compared to those only receiving standard care without this extra support.See study design

What are the potential side effects?

Since this intervention involves additional support rather than medication, typical drug side effects are not expected. However, there might be emotional or psychological impacts from discussing palliative care needs.

DeCIDE-PC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I understand information and can make decisions about my health care.

Select...

I am African American with advanced stage cancer.

Select...

I am older than 18 years.

DeCIDE-PC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months after enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months after enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who completed Advance Directives

Secondary outcome measures

Depression as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D)

Functional Assessment of Chronic Illness Therapy-Palliative Subscale (FACIT-PAL) score

Goals of care as assessed by Quality of communication (QOC) scale

+2 more

DeCIDE-PC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Standard care + DeCIDE PC interventionExperimental Treatment1 Intervention

Community health worker support and standard cancer care

Group II: Standard careActive Control1 Intervention

Standard cancer care

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,658 Previous Clinical Trials

40,924,331 Total Patients Enrolled

National Institute on Minority Health and Health Disparities (NIMHD)NIH

382 Previous Clinical Trials

1,215,851 Total Patients Enrolled

Johns Hopkins UniversityLead Sponsor

2,260 Previous Clinical Trials

14,820,470 Total Patients Enrolled

Media Library

Community Health Worker (CHW) based palliative care Clinical Trial Eligibility Overview. Trial Name: NCT05407844 — N/A

Cancer Research Study Groups: Standard care, Standard care + DeCIDE PC intervention

Cancer Clinical Trial 2023: Community Health Worker (CHW) based palliative care Highlights & Side Effects. Trial Name: NCT05407844 — N/A

Community Health Worker (CHW) based palliative care 2023 Treatment Timeline for Medical Study. Trial Name: NCT05407844 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment period for this trial still open?

"According to the data on clinicaltrials.gov, this trial is no longer actively recruiting patients as the last update was made November 8th 2022. However, there are other 2896 medical studies that have open enrollment opportunities available at present time."

Answered by AI